Bioactivity:

Lidorestat is a selective and orally active aldose reductase inhibitor (IC50: 5 nM). Lidorestat improves nerve conduction and reduces cataract formation. It can be used for chronic diabetes complications.

CAS nr:

245116-90-9

Purity:

98%

Molecular Weight:

376,35

SMILES:

OC(CN1C(C=CC=C2)=C2C(CC3=NC(C(F)=C(F)C=C4F)=C4S3)=C1)=O

Formula:

C18H11F3N2O2S

Pathway:

Others

Target:

Others